VANGUARD GROUP INC 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 09:54 am Sale | 2024-12-31 | 13G | Sana Biotechnology, Inc. SANA | VANGUARD GROUP INC | 10,747,760 4.810% | -2,435,792 (-18.48%) | Filing |
| 2024-11-12 4:52 pm Unchanged | 2024-09-30 | 13G | Sana Biotechnology, Inc. SANA | VANGUARD GROUP INC | 13,183,552 5.920% | 0 (Unchanged) | Filing |
| 2024-11-04 2:10 pm Purchase | 2024-09-30 | 13G | Sana Biotechnology, Inc. SANA | VANGUARD GROUP INC | 13,183,552 5.920% | 13,183,552 (New Position) | Filing |